1. Home
  2. NXTC
  3. NXTC News

Latest NextCure Inc. (NXTC) News on July 26, 2025

NextCure and Simcere partner to develop SIM0505 for solid tumours
NXTC

Pharmaceutical Technology

a month ago

NextCure and Simcere partner to develop SIM0505 for solid tumours

NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6
NXTC

GlobeNewswire

a month ago

NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6

NextCure, Inc. (NXTC) and LCB to Unveil Promising Preclinical Data on B7-H4 ADC at AACR 2024
NXTC

Insider Monkey

2 months ago

NextCure, Inc. (NXTC) and LCB to Unveil Promising Preclinical Data on B7-H4 ADC at AACR 2024

NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025
NXTC

GlobeNewswire

2 months ago

NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025

NextCure Provides Business Update and Reports First Quarter 2025 Financial Results
NXTC

GlobeNewswire

3 months ago

NextCure Provides Business Update and Reports First Quarter 2025 Financial Results

NextCure to Present at 24th Annual Needham Virtual Healthcare Conference
NXTC

GlobeNewswire

4 months ago

NextCure to Present at 24th Annual Needham Virtual Healthcare Conference

NextCure Provides Business Update and Reports Full Year 2024 Financial Results
NXTC

GlobeNewswire

5 months ago

NextCure Provides Business Update and Reports Full Year 2024 Financial Results

Is NextCure (NASDAQ:NXTC) In A Good Position To Invest In Growth?
NXTC

Simply Wall St.

5 months ago

Is NextCure (NASDAQ:NXTC) In A Good Position To Invest In Growth?

NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers
NXTC

GlobeNewswire

6 months ago

NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers

NextCure Announces Acceptance of IND Application for LNCB74
NXTC

GlobeNewswire

8 months ago

NextCure Announces Acceptance of IND Application for LNCB74

NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference
NXTC

GlobeNewswire

8 months ago

NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference

Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta
NXTC

GlobeNewswire

8 months ago

Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta

NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results
NXTC

GlobeNewswire

9 months ago

NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results

NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual Meeting
NXTC

GlobeNewswire

9 months ago

NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual Meeting

NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting
NXTC

GlobeNewswire

10 months ago

NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting

NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024
NXTC

GlobeNewswire

10 months ago

NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024

Is NextCure (NASDAQ:NXTC) In A Good Position To Deliver On Growth Plans?
NXTC

Simply Wall St.

a year ago

Is NextCure (NASDAQ:NXTC) In A Good Position To Deliver On Growth Plans?

NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results
NXTC

GlobeNewswire

a year ago

NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results

NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
NXTC

GlobeNewswire

a year ago

NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
NXTC

GlobeNewswire

a year ago

NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024

NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
NXTC

GlobeNewswire

a year ago

NextCure Provides Business Update and Reports First Quarter 2024 Financial Results

NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
NXTC

GlobeNewswire

a year ago

NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024

NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
NXTC

GlobeNewswire

a year ago

NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024

NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
NXTC

GlobeNewswire

a year ago

NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board

NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
NXTC

GlobeNewswire

a year ago

NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference

Will NextCure (NASDAQ:NXTC) Spend Its Cash Wisely?
NXTC

Simply Wall St.

a year ago

Will NextCure (NASDAQ:NXTC) Spend Its Cash Wisely?

NextCure to lay off 37% of staff, dial back research plans
NXTC

BioPharma Dive

a year ago

NextCure to lay off 37% of staff, dial back research plans

NextCure Provides Business Update and Reports Full Year 2023 Financial Results
NXTC

GlobeNewswire

a year ago

NextCure Provides Business Update and Reports Full Year 2023 Financial Results

NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances
NXTC

GlobeNewswire

a year ago

NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances

CompoSecure, Inc. (NASDAQ:CMPO) Shares Could Be 46% Below Their Intrinsic Value Estimate
NXTC

Simply Wall St.

a year ago

CompoSecure, Inc. (NASDAQ:CMPO) Shares Could Be 46% Below Their Intrinsic Value Estimate

Danimer Scientific Receives Continued Listing Standard Notice from NYSE
NXTC

Business Wire

a year ago

Danimer Scientific Receives Continued Listing Standard Notice from NYSE

POET Technologies Announces Closing of C$6.2 Million Non-Brokered Private Placement of Units and Reports Preliminary Unaudited Fiscal Fourth Quarter and Fiscal Year 2024 Results
NXTC

GlobeNewswire

2 years ago

POET Technologies Announces Closing of C$6.2 Million Non-Brokered Private Placement of Units and Reports Preliminary Unaudited Fiscal Fourth Quarter and Fiscal Year 2024 Results

AMERISERV FINANCIAL REPORTS EARNINGS FOR THE FULL YEAR OF 2023 AND ANNOUNCES QUARTERLY COMMON STOCK CASH DIVIDEND
NXTC

PR Newswire

2 years ago

AMERISERV FINANCIAL REPORTS EARNINGS FOR THE FULL YEAR OF 2023 AND ANNOUNCES QUARTERLY COMMON STOCK CASH DIVIDEND

Invitae sells reproductive health assets amid liquidity concerns
NXTC

MedTech Dive

2 years ago

Invitae sells reproductive health assets amid liquidity concerns

REE Completes U.S. Certification of Full-by-Wire Vehicles and Begins Customer Deliveries of its P7-C Electric Truck
NXTC

GlobeNewswire

2 years ago

REE Completes U.S. Certification of Full-by-Wire Vehicles and Begins Customer Deliveries of its P7-C Electric Truck

NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders
NXTC

GlobeNewswire

2 years ago

NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders

Surf Air Mobility Enters Agreement to Supply Electric Powertrains to Kenya’s Largest Cessna Caravan Charter Operator Z.Boskovic Air Charters
NXTC

Business Wire

2 years ago

Surf Air Mobility Enters Agreement to Supply Electric Powertrains to Kenya’s Largest Cessna Caravan Charter Operator Z.Boskovic Air Charters

Luxfer Holdings (NYSE:LXFR) Is Paying Out A Dividend Of $0.13
NXTC

Simply Wall St.

2 years ago

Luxfer Holdings (NYSE:LXFR) Is Paying Out A Dividend Of $0.13

Q4 Earnings Roundup: Constellation Brands (NYSE:STZ) And The Rest Of The Beverages and Alcohol Segment
NXTC

StockStory

2 years ago

Q4 Earnings Roundup: Constellation Brands (NYSE:STZ) And The Rest Of The Beverages and Alcohol Segment

Frequency Electronics, Inc. (NASDAQ:FEIM) is definitely on the radar of institutional investors who own 38% of the company
NXTC

Simply Wall St.

2 years ago

Frequency Electronics, Inc. (NASDAQ:FEIM) is definitely on the radar of institutional investors who own 38% of the company

Idaho Strategic Provides 2023 Year in Review
NXTC

ACCESSWIRE

2 years ago

Idaho Strategic Provides 2023 Year in Review

Bright Health Group Strengthens Capital Position with Amendment to its Credit Facility, Impending Close of the Sale of its California Medicare Advantage Business
NXTC

Business Wire

2 years ago

Bright Health Group Strengthens Capital Position with Amendment to its Credit Facility, Impending Close of the Sale of its California Medicare Advantage Business

30 Countries With Best Universities In The World
NXTC

Insider Monkey

2 years ago

30 Countries With Best Universities In The World

25 States with the Lowest Average IQ and Well Being Scores
NXTC

Insider Monkey

2 years ago

25 States with the Lowest Average IQ and Well Being Scores

Here's Why NextCure, Inc. (NXTC) Looks Ripe for Bottom Fishing
NXTC

Zacks

2 years ago

Here's Why NextCure, Inc. (NXTC) Looks Ripe for Bottom Fishing

NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury
NXTC

GlobeNewswire

2 years ago

NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury

5 Secret Santa Stocks to Pop Surprise Returns
NXTC

Zacks

2 years ago

5 Secret Santa Stocks to Pop Surprise Returns

Tigo Energy Appoints Sagit Manor to Board of Directors
NXTC

Business Wire

2 years ago

Tigo Energy Appoints Sagit Manor to Board of Directors

NextCure (NXTC) Down on Shelving Plans to Develop Candidate
NXTC

Zacks

2 years ago

NextCure (NXTC) Down on Shelving Plans to Develop Candidate

NextCure Provides Year-End Clinical Pipeline Updates
NXTC

GlobeNewswire

2 years ago

NextCure Provides Year-End Clinical Pipeline Updates

Phunware Announces Closing of $2.8 Million Public Offering
NXTC

GlobeNewswire

2 years ago

Phunware Announces Closing of $2.8 Million Public Offering

NXTC

Associated Press Finance

2 years ago

Delta Apparel: Fiscal Q4 Earnings Snapshot

Delta Apparel Reports Fourth Quarter and Full Year Fiscal 2023 Results
NXTC

Business Wire

2 years ago

Delta Apparel Reports Fourth Quarter and Full Year Fiscal 2023 Results

Director Scott Flanders' Strategic Investment in Fathom Holdings Inc
NXTC

GuruFocus.com

2 years ago

Director Scott Flanders' Strategic Investment in Fathom Holdings Inc

NXTC

Business Wire

2 years ago

Phunware Announces Pricing of $2.8 Million Public Offering

Phunware Launches Proposed Public Offering of Securities
NXTC

GlobeNewswire

2 years ago

Phunware Launches Proposed Public Offering of Securities

3 Underperforming Bank Stocks You Better Not Be Buying
NXTC

InvestorPlace

2 years ago

3 Underperforming Bank Stocks You Better Not Be Buying

IceCure's ProSense® Deepens Regulatory Approval in India
NXTC

PR Newswire

2 years ago

IceCure's ProSense® Deepens Regulatory Approval in India

After Plunging -17.65% in 4 Weeks, Here's Why the Trend Might Reverse for InflaRx N.V. (IFRX)
NXTC

Zacks

2 years ago

After Plunging -17.65% in 4 Weeks, Here's Why the Trend Might Reverse for InflaRx N.V. (IFRX)

BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC
NXTC

GlobeNewswire

2 years ago

BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC

Orion Group Holdings, Inc. Names Chip Earle as General Counsel
NXTC

GlobeNewswire

2 years ago

Orion Group Holdings, Inc. Names Chip Earle as General Counsel

Deswell Industries, Inc. (NASDAQ:DSWL) Pays A US$0.10 Dividend In Just Three Days
NXTC

Simply Wall St.

2 years ago

Deswell Industries, Inc. (NASDAQ:DSWL) Pays A US$0.10 Dividend In Just Three Days

Acrivon Therapeutics to Present at the Piper Sandler Annual Healthcare Conference
NXTC

GlobeNewswire

2 years ago

Acrivon Therapeutics to Present at the Piper Sandler Annual Healthcare Conference

Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NXTC

GlobeNewswire

2 years ago

Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference
NXTC

GlobeNewswire

2 years ago

NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference

NXTC

PR Newswire

2 years ago

OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp.

Down -84.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Aclaris (ACRS)
NXTC

Zacks

2 years ago

Down -84.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Aclaris (ACRS)

Lava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
NXTC

GlobeNewswire

2 years ago

Lava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results

NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525, a Novel LAIR-1 Antibody for AML
NXTC

GlobeNewswire

2 years ago

NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525, a Novel LAIR-1 Antibody for AML

NXTC

South China Morning Post

2 years ago

Lufax to acquire Hong Kong virtual lender Ping An OneConnect Bank for US$119.5 million

OneConnect Announces Third Quarter and Nine Months Ended September 30, 2023 Unaudited Financial Results
NXTC

PR Newswire

2 years ago

OneConnect Announces Third Quarter and Nine Months Ended September 30, 2023 Unaudited Financial Results

Spruce Power Holding Corporation (NYSE:SPRU) Q3 2023 Earnings Call Transcript
NXTC

Insider Monkey

2 years ago

Spruce Power Holding Corporation (NYSE:SPRU) Q3 2023 Earnings Call Transcript

Inuvo, Inc. (AMEX:INUV) Q3 2023 Earnings Call Transcript
NXTC

Insider Monkey

2 years ago

Inuvo, Inc. (AMEX:INUV) Q3 2023 Earnings Call Transcript

Great Elm Group, Inc. (NASDAQ:GEG) Q1 2024 Earnings Call Transcript
NXTC

Insider Monkey

2 years ago

Great Elm Group, Inc. (NASDAQ:GEG) Q1 2024 Earnings Call Transcript

Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD
NXTC

GlobeNewswire

2 years ago

Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD

Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®
NXTC

GlobeNewswire

2 years ago

Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®

PMV Pharmaceuticals Inc (PMVP) Reports Q3 2023 Financial Results and Corporate Updates
NXTC

GuruFocus.com

2 years ago

PMV Pharmaceuticals Inc (PMVP) Reports Q3 2023 Financial Results and Corporate Updates

NXTC

GuruFocus.com

2 years ago

Great Elm Group Inc Reports Substantial Revenue Growth and Net Income Turnaround in Q1 Fiscal 2024

NXTC

Associated Press Finance

2 years ago

Great Elm: Fiscal Q1 Earnings Snapshot

Integra Files Technical Report for Updated Mineral Resource Estimate at the DeLamar Project
NXTC

GlobeNewswire

2 years ago

Integra Files Technical Report for Updated Mineral Resource Estimate at the DeLamar Project

All You Need to Know About NextCure, Inc. (NXTC) Rating Upgrade to Buy
NXTC

Zacks

2 years ago

All You Need to Know About NextCure, Inc. (NXTC) Rating Upgrade to Buy

NXTC

GuruFocus.com

2 years ago

Outbrain Inc (OB) Announces 8% YoY Growth in Ex-TAC Gross Profit for Q3 2023

Outbrain Announces Third Quarter 2023 Results
NXTC

GlobeNewswire

2 years ago

Outbrain Announces Third Quarter 2023 Results

Best Value Stocks to Buy for November 6th
NXTC

Zacks

2 years ago

Best Value Stocks to Buy for November 6th

Does Natural Health Trends (NASDAQ:NHTC) Deserve A Spot On Your Watchlist?
NXTC

Simply Wall St.

2 years ago

Does Natural Health Trends (NASDAQ:NHTC) Deserve A Spot On Your Watchlist?

Natural Health Trends Corp. (NASDAQ:NHTC) Q3 2023 Earnings Call Transcript
NXTC

Insider Monkey

2 years ago

Natural Health Trends Corp. (NASDAQ:NHTC) Q3 2023 Earnings Call Transcript

Applied Therapeutics to Host Diabetic Cardiomyopathy Expert Forum with Key Opinion Leaders on Tuesday, November 7
NXTC

GlobeNewswire

2 years ago

Applied Therapeutics to Host Diabetic Cardiomyopathy Expert Forum with Key Opinion Leaders on Tuesday, November 7

Share on Social Networks: